Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1434-9949
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis ; day:16 ; month:8 ; year:2022 ; pages:1-13
Clinical rheumatology ; (16.8.2022), 1-13
- Urheber
-
Khader, Yasmin
Beran, Azizullah
Ghazaleh, Sami
Lee-Smith, Wade
Altorok, Nezam
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10067-022-06307-8
- URN
-
urn:nbn:de:101:1-2022110322443644304827
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Khader, Yasmin
- Beran, Azizullah
- Ghazaleh, Sami
- Lee-Smith, Wade
- Altorok, Nezam
- SpringerLink (Online service)
Ähnliche Objekte (12)
Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics
Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologics
Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial
Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care
Predictors of chronic migraine remission
Real-world retention rates of biologics in patients with rheumatoid arthritis
Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study
Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs
Residual metabolic burden in young psoriasis patients successfully treated with biologics
Methotrexate treatment before use of biologics in rheumatoid arthritis: Analysis of guideline compliance
Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics
Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologics
Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial
Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care
Predictors of chronic migraine remission
Real-world retention rates of biologics in patients with rheumatoid arthritis
Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study
Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs
Residual metabolic burden in young psoriasis patients successfully treated with biologics
Methotrexate treatment before use of biologics in rheumatoid arthritis: Analysis of guideline compliance
Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics
Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologics
Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial
Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care
Predictors of chronic migraine remission
Real-world retention rates of biologics in patients with rheumatoid arthritis
Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study
Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs
Residual metabolic burden in young psoriasis patients successfully treated with biologics